The researchers showed that one specific type of LPS, called O26:B6, is particularly good at setting off this reaction, making it more likely to cause clotting problems. Sepsis is a dangerous ...
A randomized, double-blind, Phase II clinical study (the Lipid Infusion and Patient Outcomes in Sepsis [LIPOS] study) tested the safety and efficacy of one phospholipid-rich emulsion, namely ...
The failure of most clinical trials has led to considerable consideration regarding the future of immunotherapy in sepsis. Most of these trials studied the efficacy of agents that block pro ...